Genome Technologies Coordinating Center

基因组技术协调中心

基本信息

  • 批准号:
    10571905
  • 负责人:
  • 金额:
    $ 149.81万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-05-20 至 2025-02-28
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY The Genome Technology portfolio at NHGRI encompasses a substantial diversity of scientific approaches and objectives, from instrumentation development to high-throughput application of technologies to characterizing the genomic basis for phenotypic traits. These research efforts have produced significant insight into biology and disease, and yet there are many opportunities to accelerate innovation, development, and early dissemination of genomic technologies. The goal of the Genome Technology Coordinating Center (GTCC) is to maximize these opportunities by liaising grantees and NHGRI Program Staff, managing research funds, and developing educational resources to support and tout the excellence of the Genome Technology program. We propose the following aims to meet these goals: 1) Facilitate collaborations across the Genome Technology Program and promote standards that aid in achieving Program goals. We will host and support Annual meetings for the Genome Technology and CEGS programs. We will also develop Working Groups among grantees to promote collaboration-building and the development of metrics and standards for genomic technologies. We will use these Working Groups to identify gaps in the field that will provide the foundation for solicitation of Opportunity Funds. 2) Establish and manage an Opportunity Funds program to support initial development of promising new technologies and ideas. These Opportunity Funds will be distributed as pilot projects (early stage or proof-of- principle studies) and development projects (comparatively advanced studies with supportive preliminary data) in years 2-4. Peer review will be conducted by an External Review Panel of experts in genomic technology. 3) Implement community outreach activities to encourage awareness of Genome Technology Program successes and facilitate access by the scientific community. We will develop and manage an Education and Outreach Working Group composed of grantees and educational experts to identify and prioritize areas of development for educational materials, and host and advertise a website to distribute those materials. A targeted effort will be made to expose underrepresented and underserved populations in science to the advances and importance of the Genome Technology Program. Informational resources related to technology transfer and intellectual property will be developed for grantees. The Jackson Laboratory (JAX) is uniquely qualified to serve as the GTCC for the Genome Technology Program. The Laboratory has over ninety years of history in supporting mammalian genetics research including through the provision of widely used information resources (e.g. Mouse Genome Informatics) and educational programs including the Annual Short Course on Experimental Models of Human Cancer (29 years), and the McKusick Short Course on Human and Mammalian Genetics and Genomics (nearly 60 years). The Jackson Laboratory for Genomic Medicine was established in 2012 to apply the Lab’s expertise in genomics and technology development toward improvements in genome-based medicine.
项目概要 NHGRI 的基因组技术组合涵盖了多种科学方法和 目标,从仪器开发到技术的高通量应用再到表征 这些研究工作对生物学和表型性状的基因组基础产生了重要的见解。 疾病,但仍有许多机会加速创新、发展和早期传播 基因组技术协调中心 (GTCC) 的目标是最大限度地利用这些技术。 通过联络受资助者和 NHGRI 项目工作人员、管理研究资金以及开发 我们建议提供教育资源来支持和宣扬基因组技术计划的卓越性。 以下目标旨在实现这些目标: 1) 促进基因组技术计划之间的合作 我们将主办和支持年度会议,以促进有助于实现计划目标的标准。 我们还将在受资助者之间建立工作组来促进基因组技术和 CEGS 项目的发展。 我们将利用这些来建立合作并制定基因组技术的指标和标准。 工作组确定该领域的差距,为募集机会基金奠定基础。 2) 建立和管理机会基金计划,以支持有前景的新产品的初步开发 这些机会基金将作为试点项目(早期或验证项目)进行分配。 研究)和开发项目(具有支持性初步数据的比较先进的研究) 第 2-4 年,同行评审将由基因组技术专家组成的外部评审小组进行。 实施社区外展活动,以鼓励人们了解基因组技术计划的成功 我们将开发和管理教育和外展活动。 由受资助者和教育专家组成的工作组,负责确定发展领域并确定优先顺序 教育材料,并主办和宣传一个网站来分发这些材料。 旨在让科学界代表性不足和服务不足的人群了解科学的进步和重要性 基因组技术计划与技术转让和知识产权相关的信息资源。 杰克逊实验室 (JAX) 是唯一有资格作为受资助者开发的财产。 GTCC 基因组技术计划实验室在支持基因组技术计划方面拥有九十多年的历史。 哺乳动物遗传学研究,包括通过提供广泛使用的信息资源(例如小鼠 基因组信息学)和教育计划,包括年度实验模型短期课程 人类癌症(29 岁),以及 McKusick 人类和哺乳动物遗传学和基因组学短期课程 (近60年)杰克逊基因组医学实验室成立于2012年,以应用实验室的成果。 基因组学和技术开发方面的专业知识,以改进基于基因组的医学。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Mark D ADAMS其他文献

Mark D ADAMS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Mark D ADAMS', 18)}}的其他基金

Genome Technologies Coordinating Center
基因组技术协调中心
  • 批准号:
    10213304
  • 财政年份:
    2021
  • 资助金额:
    $ 149.81万
  • 项目类别:
Genome Technologies Coordinating Center
基因组技术协调中心
  • 批准号:
    10408042
  • 财政年份:
    2021
  • 资助金额:
    $ 149.81万
  • 项目类别:
Modular Platform for Combinatorial Epigenome Manipulation
用于组合表观基因组操作的模块化平台
  • 批准号:
    10592628
  • 财政年份:
    2018
  • 资助金额:
    $ 149.81万
  • 项目类别:
A Digital Microfluidic Systems for Gene Synthesis, Sequencing and Recovery
用于基因合成、测序和恢复的数字微流控系统
  • 批准号:
    8352845
  • 财政年份:
    2012
  • 资助金额:
    $ 149.81万
  • 项目类别:
A Digital Microfluidic Systems for Gene Synthesis, Sequencing and Recovery
用于基因合成、测序和恢复的数字微流控系统
  • 批准号:
    8532939
  • 财政年份:
    2012
  • 资助金额:
    $ 149.81万
  • 项目类别:
Impact of Mitochondrial Genome Variation on extreme Prostate Cancer Disparities
线粒体基因组变异对前列腺癌极端差异的影响
  • 批准号:
    8519389
  • 财政年份:
    2012
  • 资助金额:
    $ 149.81万
  • 项目类别:
Evolution of multidrug resistance in Acinetobacter baumannii
鲍曼不动杆菌多重耐药性的演变
  • 批准号:
    8535790
  • 财政年份:
    2011
  • 资助金额:
    $ 149.81万
  • 项目类别:
Evolution of multidrug resistance in Acinetobacter baumannii
鲍曼不动杆菌多重耐药性的演变
  • 批准号:
    8325561
  • 财政年份:
    2011
  • 资助金额:
    $ 149.81万
  • 项目类别:
Genomics
基因组学
  • 批准号:
    8555234
  • 财政年份:
    2011
  • 资助金额:
    $ 149.81万
  • 项目类别:
Evolution of multidrug resistance in Acinetobacter baumannii
鲍曼不动杆菌多重耐药性的演变
  • 批准号:
    8107146
  • 财政年份:
    2011
  • 资助金额:
    $ 149.81万
  • 项目类别:

相似海外基金

Developing a Patient Navigation Intervention to Improve Risk Management among Women at High Risk of Breast Cancer
制定患者导航干预措施以改善乳腺癌高危女性的风险管理
  • 批准号:
    10593675
  • 财政年份:
    2023
  • 资助金额:
    $ 149.81万
  • 项目类别:
COVID-19 Telehealth Policies' Impact on Provision of Alcohol and Substance Use Disorder Services at Federally Qualified Health Centers
COVID-19 远程医疗政策对联邦合格健康中心提供酒精和药物滥用障碍服务的影响
  • 批准号:
    10662155
  • 财政年份:
    2023
  • 资助金额:
    $ 149.81万
  • 项目类别:
Improving Function and Reducing Opioid Use for Patients with Chronic Low Back Pain in Rural Communities through Improved Access to Physical Therapy using Telerehabilitation
通过远程康复改善物理治疗的可及性,改善农村社区慢性腰痛患者的功能并减少阿片类药物的使用
  • 批准号:
    10745146
  • 财政年份:
    2023
  • 资助金额:
    $ 149.81万
  • 项目类别:
Rumbo: An Integrated Mobile and Web-Based Application to Overcome Barriers to Receive Substance Use Disorder (SUD) Treatment and Improve Outcomes for Spanish-Speaking, Hispanic and Latinx Individuals
Rumbo:一款基于移动和网络的集成应用程序,用于克服接受药物滥用障碍 (SUD) 治疗的障碍并改善西班牙语、西班牙裔和拉丁裔个人的治疗结果
  • 批准号:
    10601173
  • 财政年份:
    2023
  • 资助金额:
    $ 149.81万
  • 项目类别:
HD2A RASC-SUD Implementation Support Core
HD2A RASC-SUD 实施支持核心
  • 批准号:
    10708983
  • 财政年份:
    2022
  • 资助金额:
    $ 149.81万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了